Sanofi Rises 3% on Q1 Beats, CEO Coronavirus Vaccine Comments
Sanofi (NASDAQ: SNY) ended the week on an up note, buoyed by an encouraging quarterly earnings release and market-pleasing remarks its CEO made about potential SARS-CoV-2 coronavirus vaccine manufacturing.
For the pharmaceutical giant's Q1 of fiscal 2020, according to International Financial Reporting Standards, its net sales were 8.97 billion euros ($9.70 billion). That was nearly 7% higher on a year-over-year basis. Net income was 2.04 billion euros ($2.21 billion), an improvement of almost 16%. On a per-share basis, net profit was 1.63 euros ($1.76).
Image source: Getty Images.
Source Fool.com
